Structural and functional imaging of normal bone marrow and evaluation of its age-related changes.

A number of noninvasive imaging techniques have been used for the evaluation of bone marrow, including magnetic resonance imaging (MRI) and bone marrow scintigraphy. The appearance of bone marrow on MRI varies considerably depending on the proportion of red and yellow marrow, and the composition of the red marrow and its distribution with relation to age and sex. The composition of bone marrow also can vary under physiological and pathological conditions. MRI is a highly sensitive technique for evaluating the bone marrow, but it is limited in its practical use for whole-body bone marrow screening. Bone marrow scintigraphy with radiolabeled compounds such as technetium-99m-labeled nanocolloid and monoclonal antibodies has the advantage of evaluating the entire bone marrow, and has been used for the diagnosis of various bone marrow disorders. In addition, (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging can be used to evaluate bone marrow metabolism and disease and to provide information about the state of the primary tumor, lymph nodes, and distant metastases. Understanding of the appearance of normal bone marrow, including age- and sex-specific differences with each of these imaging modalities, is essential to permit accurate diagnosis of benign and malignant bone marrow disorders. We present a review of MRI and scintigraphy of normal bone marrow with some emphasis on FDG-PET imaging in assessing marrow activity in normal and abnormal states and also present preliminary data regarding normal age-related changes in bone marrow through use of FDG-PET, as well as the role of segmentation of bone marrow on MRI for quantitative calculation of the metabolic volumetric product for red marrow metabolism using FDG-PET.

[1]  J. M. Ollinger,et al.  Positron Emission Tomography , 2018, Handbook of Small Animal Imaging.

[2]  S Chandler,et al.  Bone marrow hypervascularity in patients with myelofibrosis identified by infra-red thermography. , 2008, Clinical and laboratory haematology.

[3]  Abass Alavi,et al.  PET: a revolution in medical imaging. , 2004, Radiologic clinics of North America.

[4]  A. Alavi,et al.  Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. , 2004, Seminars in nuclear medicine.

[5]  J. Herndon,et al.  Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. , 2004, Lung cancer.

[6]  A. Rahmouni,et al.  Normal spinal bone marrow in adults: dynamic gadolinium-enhanced MR imaging. , 2003, Radiology.

[7]  E. Bednarczyk,et al.  Interaction of Colony-Stimulating Factors and Fluorodeoxyglucose F18 Positron Emission Tomography , 2002, The Annals of pharmacotherapy.

[8]  O. Schober,et al.  Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. , 2001, AJR. American journal of roentgenology.

[9]  W. Heindel,et al.  Age‐ and sex‐specific differences in the 1H‐spectrum of vertebral bone marrow , 2001, Journal of magnetic resonance imaging : JMRI.

[10]  Segall,et al.  Comparison of FDG-PET and Bone Scans for Detecting Skeletal Metastases in Patients with Non-small Cell Lung Cancer. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[11]  M. Meyer,et al.  Reduced F-18 fluorodeoxyglucose uptake within marrow after external beam radiation. , 2000, Clinical nuclear medicine.

[12]  R. Wahl,et al.  Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  G. Rosen,et al.  Fluorine-18 fluorodeoxyglucose splenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation. , 1999, Clinical nuclear medicine.

[14]  B. Maldague,et al.  Magnetic resonance imaging of the normal bone marrow , 1998, Skeletal Radiology.

[15]  A. Green,et al.  Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. , 1998, Clinical nuclear medicine.

[16]  B. Maldague,et al.  MR assessment of red marrow distribution and composition in the proximal femur: correlation with clinical and laboratory parameters , 1997, Skeletal Radiology.

[17]  H. Ishizaka,et al.  Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex. , 1996, AJR. American journal of roentgenology.

[18]  P. Parizel,et al.  Influence of Magnetic Field Strength on T2* Decay and Phase Effects in Gradient Echo MRI of Vertebral Bone Marrow , 1995, Journal of computer assisted tomography.

[19]  C D Claussen,et al.  Normal bone marrow in the sacrum of young adults: differences between the sexes seen on chemical-shift MR imaging. , 1995, AJR. American journal of roentgenology.

[20]  A. Saifuddin,et al.  Bone marrow blood supply in gadolinium-enhanced magnetic resonance imaging , 1994, Skeletal Radiology.

[21]  Dewey Odhner,et al.  3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system , 1994, Medical Imaging.

[22]  W. D. Murphy,et al.  Bone marrow reconversion in adults who are smokers: MR Imaging findings. , 1993, AJR. American journal of roentgenology.

[23]  J. Kempf,et al.  Diffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  G. Sze,et al.  Developing spinal column: gadolinium-enhanced MR imaging. , 1991, Radiology.

[25]  A. Rahmouni,et al.  Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. , 1990, Radiology.

[26]  N. Rilinger,et al.  Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow , 1990, The Lancet.

[27]  S. Reske,et al.  RADIOIMMUNOIMAGING FOR DIAGNOSIS OF BONE MARROW INVOLVEMENT IN BREAST CANCER AND MALIGNANT LYMPHOMA , 1989, The Lancet.

[28]  W A Murphy,et al.  Bone marrow imaging. , 1988, Radiology.

[29]  D G Mitchell,et al.  The biophysical basis of tissue contrast in extracranial MR imaging. , 1987, AJR. American journal of roentgenology.

[30]  L. Klassen,et al.  Bone marrow patterns in aplastic anemia: observations with 1.5-T MR imaging. , 1987, Radiology.

[31]  Pavel Dg,et al.  Bone marrow imaging: a comparison study using a 99Tcm-sulphur colloid versus a new 99Tcm-microaggregated albumin. , 1986, Nuclear medicine communications.

[32]  D. Mitchell,et al.  Hematopoietic and fatty bone marrow distribution in the normal and ischemic hip: new observations with 1.5-T MR imaging. , 1986, Radiology.

[33]  F. Datz,et al.  The clinical use of radionuclide bone marrow imaging. , 1985, Seminars in nuclear medicine.

[34]  M. Thakur,et al.  Radiopharmaceuticals for spleen and bone marrow studies. , 1985, Seminars in nuclear medicine.

[35]  H. Hricak,et al.  Bone marrow imaging: magnetic resonance studies related to age and sex. , 1985, Radiology.

[36]  A. Harłozińska,et al.  Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series. , 1985, British Journal of Cancer.

[37]  A. Hotze,et al.  [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases]. , 1984, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[38]  J R MacFall,et al.  Mechanisms of Contrast in NMR Imaging , 1984, Journal of computer assisted tomography.

[39]  G. Gahrton,et al.  Clinical evaluation of NCA in patients with chronic myelocytic leukemia , 1982, International journal of cancer.

[40]  A. Ali,et al.  Radionuclide imaging of bone marrow. , 1981, Seminars in hematology.

[41]  M. Cristy,et al.  Active bone marrow distribution as a function of age in humans. , 1981, Physics in medicine and biology.

[42]  P. Jacobs.  Bone-marrow aspiration and trephine biopsy. , 1980, British medical journal.

[43]  S. Knowles,et al.  Bone-marrow aspiration and trephine biopsy (2). , 1980, British medical journal.

[44]  A. V. Hoffbrand,et al.  Bone-marrow aspiration and trephine biopsy (1). , 1980, British medical journal.

[45]  G. Gahrton,et al.  Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients. , 1980, Cancer research.

[46]  L. Hjorth,et al.  OSTEOPOROSIS OF AGEING , 1976, The Lancet.

[47]  E. Brown,et al.  The metabolism of transferrin-bound 111In and 59Fe in the rat. , 1974, Blood.

[48]  R. E. Bower,et al.  The quantitative distribution of the erythron and the RE cell in the bone marrow organ of man. , 1969, Blood.

[49]  J A Anderson,et al.  Quantitative histological studies on age changes in bone. , 1967, The Journal of pathology and bacteriology.

[50]  H. Anger,et al.  Differences in distribution of erythropoietic and reticuloendothelial marrow in hematologic disease. , 1967, Blood.

[51]  L. Schiffer,et al.  Erythropoietic and Reticuloendothelial Function in Bone Marrow in Dogs , 1966, Science.

[52]  C S PETTY,et al.  NORMAL VARIATIONS WITH AGING OF THE AMOUNT OF HEMATOPOIETIC TISSUE IN BONE MARROW FROM THE ANTERIOR ILIAC CREST. A STUDY MADE FROM 177 CASES OF SUDDEN DEATH EXAMINED BY NECROPSY. , 1965, American journal of clinical pathology.

[53]  M. Hashimoto.  Pathology of bone marrow. , 1962, Acta haematologica.

[54]  S. Reske,et al.  Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution , 2004, European Journal of Nuclear Medicine.

[55]  S. Majumdar,et al.  Hematopoietic bone marrow in the adult knee: spin-echo and opposed-phase gradient-echo MR imaging , 2004, Skeletal Radiology.

[56]  M. Kricun.  Red-yellow marrow conversion: Its effect on the location of some solitary bone lesions , 2004, Skeletal Radiology.

[57]  R L Wahl,et al.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[58]  L. Larsson,et al.  In vivo localization of colloidal Au198 intravenously injected in polycythemia vera; a preliminary report. , 1958, Acta radiologica.